Stephanie Gaillard

15PUBLICATIONS
126CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Aug 29, 2026
The new (version 9) American Joint Committee on Cancer (AJCC) tumor-node-metastasis (TNM) staging protocol for carcinoma of the vulva.

|Dec 11, 2025
Molecular Profiling and Tumor Biomarker Analysis of GOG281/LOGS: A Positive Late-Phase Trial of Trametinib for Recurrent/Persistent Low-Grade Serous Ovarian Carcinoma.

Robert L Hollis, Austin Miller, Heather A Lankes

|Jul 14, 2025
Inhibition of Glutamine Metabolism Attenuates Tumor Progression Through Remodeling of the Macrophage Immune Microenvironment.

Tianhe Li, Sepehr Akhtarkhavari, Sumeng Qi

|May 09, 2025
Rare Uterine Tumors: What to Do?

Erin Crane, Stéphanie Gaillard, Martee Leigh Hensley

|Mar 28, 2025
FOLR1 as a therapeutic target in platinum-resistant ovarian carcinoma: unique expression patterns across ovarian carcinoma histotypes and molecular subtypes of low-grade serous carcinoma.

Yuen Yee Leung, Marta Llaurado-Fernandez, Anna Cameron

|Jan 27, 2025
Inhibition of Glutamine Metabolism Suppresses Tumor Progression through Remodeling of the Macrophage Immune Microenvironment.

Tianhe Li, Sepehr Akhtarkhavari, Tu-Yung Chang

Pageof 3

Frequent Collaborators

5 joint publications

Ie-Ming Shih

4 joint publications

Tian-Li Wang

3 joint publications

Deborah K Armstrong

2 joint publications

Christina Lacchetti